- Home
- WDH vs LBRX Comparison
WDH vs LBRX Comparison
Compare WDH & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WDH | LBRX |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 647.4M | 563.2M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | WDH | LBRX |
|---|---|---|
| Price | $1.90 | $20.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $49.00 |
| AVG Volume (30 Days) | 413.0K | ★ 531.3K |
| Earning Date | 12-03-2025 | 02-15-2026 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | ★ 75.20 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $456,980,701.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.60 | N/A |
| P/E Ratio | $9.66 | ★ N/A |
| Revenue Growth | ★ 18.55 | N/A |
| 52 Week Low | $1.08 | $13.36 |
| 52 Week High | $2.18 | $23.15 |
Technical Indicators
Market Signals| Indicator | WDH | LBRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.93 | N/A |
| Support Level | $1.80 | N/A |
| Resistance Level | $1.94 | N/A |
| Average True Range (ATR) | 0.09 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 62.00 | 0.00 |
Price Performance
Historical ComparisonAbout WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
About LBRX LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.